1. Home
  2. EXPO vs ABCL Comparison

EXPO vs ABCL Comparison

Compare EXPO & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exponent Inc.

EXPO

Exponent Inc.

HOLD

Current Price

$66.53

Market Cap

3.2B

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$12.70

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXPO
ABCL
Founded
1967
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.5B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
EXPO
ABCL
Price
$66.53
$12.70
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$88.00
$8.40
AVG Volume (30 Days)
346.8K
4.4M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
1.87%
N/A
EPS Growth
N/A
10.91
EPS
1.19
N/A
Revenue
$582,014,000.00
$75,128,000.00
Revenue This Year
$12.75
N/A
Revenue Next Year
$8.50
$21.85
P/E Ratio
$56.40
N/A
Revenue Growth
4.21
160.56
52 Week Low
$51.91
$2.75
52 Week High
$81.95
$13.18

Technical Indicators

Market Signals
Indicator
EXPO
ABCL
Relative Strength Index (RSI) 50.32 65.43
Support Level $64.38 $10.38
Resistance Level $69.46 N/A
Average True Range (ATR) 1.52 0.59
MACD -0.30 -0.00
Stochastic Oscillator 35.81 79.02

Price Performance

Historical Comparison
EXPO
ABCL

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: